840 related articles for article (PubMed ID: 20367285)
1. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
4. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
[TBL] [Abstract][Full Text] [Related]
8. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
Nekanti U; Rao VB; Bahirvani AG; Jan M; Totey S; Ta M
Stem Cells Dev; 2010 Jan; 19(1):117-30. PubMed ID: 19619003
[TBL] [Abstract][Full Text] [Related]
9. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
10. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
11. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells.
Panepucci RA; Siufi JL; Silva WA; Proto-Siquiera R; Neder L; Orellana M; Rocha V; Covas DT; Zago MA
Stem Cells; 2004; 22(7):1263-78. PubMed ID: 15579645
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.
Wu LF; Wang NN; Liu YS; Wei X
Tissue Eng Part A; 2009 Oct; 15(10):2865-73. PubMed ID: 19257811
[TBL] [Abstract][Full Text] [Related]
16. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.
Choi M; Lee HS; Naidansaren P; Kim HK; O E; Cha JH; Ahn HY; Yang PI; Shin JC; Joe YA
Int J Biochem Cell Biol; 2013 Mar; 45(3):560-70. PubMed ID: 23246593
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
[TBL] [Abstract][Full Text] [Related]
18. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
